Galderma is the leading company solely dedicated to skin and advancing the future of dermatology. We deliver an innovative, science-based portfolio of sophisticated brands and services across Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Through trusted partnerships with healthcare professionals, we ensure to meet individual consumer and patient needs with superior outcomes.
解鎖市場時間軸與訊號動態
過去 90 日內有 306 個訊號。
此公司進入各市場的次序 — 由最舊至最新
13 active postings
70 active postings
註冊以查看完整訊號動態
Galderma 的國際擴張與競爭對手的比較
Galderma你長條顯示所比較各公司之間的相對規模。
欄位5| 公司 | 市場 | 新市場 | 動能 | 活動 | 擴張評分 |
|---|---|---|---|---|---|
 Galderma你 | 34 | 0 | -57% | 250 | 35 |
Opérateur de Production Conditionnement FDS Jour
查看招聘Baie-d’Urfé, Quebec, Canada · 昨日
Employee Relations / Labor Relations (ER / LR) Specialist (Part-time position / 50%)
查看招聘Warsaw, Mazowieckie, Poland · 昨日
Sales Representative (Injectable Aesthetics) - Western Cape Town
查看招聘Johannesburg, Gauteng, South Africa · 前日
We’re excited to share insights from our new global anti-wrinkle treatment survey, revealing a clear shift in preferences toward high-performance solutions that deliver lasting results and drive innovation in aesthetics.Anti-wrinkle treatments are one of the most common injectable procedures in aesthetics. Results show that healthcare professionals prioritize performance above all. For patients, the value lies in both emotional impact and visible performance, with long-lasting and early results ...
已結束We’re excited to share insights from our new global anti-wrinkle treatment survey, revealing a clear shift in preferences toward high-performance solutions that deliver lasting results and drive innovation in aesthetics.Anti-wrinkle treatments are one of the most common injectable procedures in aesthetics. Results show that healthcare professionals prioritize performance above all. For patients, the value lies in both emotional impact and visible performance, with long-lasting and early results ...
已結束At Galderma, the President’s Club Awards are an opportunity to recognize our top-performing Sales colleagues from around the world. This year we held two exceptional events - first, in May, our leading U.S. Sales colleagues gathered in Cap Cana, Dominican Republic, for a well-earned celebration of their remarkable achievements.Then, just this past week, our top Sales colleagues from LATAM, EMEAC and JPAC joined together in Singapore, all in one place for the very first time. These celebrations r ...
已結束高德美韓國推出適樂膚SA系列,專為敏感肌膚去角質。產品包括溫和去角質潔面乳和乳液,含三重去角質成分和保濕成分。
嘉德瑪推出IL-31抑制劑奈莫利珠單抗，用於治療特應性皮炎和結節性癢疹，已在韓國獲批，進軍生物製劑市場。
Galderma韓國推出Nemolizumab,一種IL-31抑制劑,針對異位性皮膚炎和結節性癢疹的搔癢。臨床試驗顯示48小時內快速緩解搔癢及顯著EASI改善。已完成給付申請,目標2027年初上市。
解鎖已驗證電郵與直撥電話
免費 · 無需信用卡
關於 Galderma 業務、市場及增長訊號的快速解答。
